A class action lawsuit has been filed against Helen of Troy Limited and certain officers for allegedly misleading investors about the success of its Project Pegasus initiative between April 2024 and October 2025. The complaint claims the company overstated cost-saving benefits and downplayed operational issues, leading to false and misleading statements about its business prospects. Investors who purchased Helen of Troy securities during this period are encouraged to join the lawsuit and may request lead plaintiff status by August 3, 2026. The law firm Bronstein, Gewirtz & Grossman is handling the case on a contingency fee basis, meaning no upfront cost for investors.
Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, co...
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
Cardone Capital purchased an additional 282 Bitcoin valued at about $18 million as Bitcoin traded near $63,000 amid geopolitical tensions. The firm funds its Bitcoin acquisitions through rental income from multifamily real estate properties, using a ...
